Patent · US Active

Compounds and methods for the targeted degradation of bromodomain-containing proteins

US10772962B2 · kind B2 · utility

9Cited by
12References
23Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 5, 2016
Grant dateSep 15, 2020
Priority date
Expiry dateAug 5, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand which binds to the ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. The present invention exhibits a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of targeted polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.